Literature DB >> 3582916

Positive intravenous secretin test in patients with achlorhydria-related hypergastrinemia.

M Feldman, L R Schiller, J H Walsh, J S Fordtran, C T Richardson.   

Abstract

The intravenous secretin test is widely used to distinguish gastrinoma (Zollinger-Ellison syndrome) from other causes of fasting hypergastrinemia. We report 2 patients with fasting hypergastrinemia and a rise of greater than 200 pg/ml in serum gastrin concentration after intravenous injection of 2 CU/kg body wt of pure natural secretin. Both patients had pentagastrin-fast achlorhydria. Thus, the intravenous secretin test may be positive in patients with achlorhydria-related hypergastrinemia. Gastric acid secretion should be measured in hypergastrinemic patients before embarking on a secretin test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3582916     DOI: 10.1016/0016-5085(87)90314-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  7 in total

Review 1.  Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.

Authors:  Tetsuhide Ito; Guillaume Cadiot; Robert T Jensen
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

2.  Searching for gastrinomas.

Authors:  P J Hammond; S R Bloom
Journal:  BMJ       Date:  1993-07-03

3.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

4.  Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome.

Authors:  Pari Shah; Maneesh H Singh; Yu-Xiao Yang; David C Metz
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

5.  Zollinger-Ellison syndrome in a patient with normal screening gastrin level.

Authors:  R J Yanda; J W Ostroff; C D Ashbaugh; M S Guis; H I Goldberg
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

6.  Patterns of gastrin secretion in patients with nonfunctioning pituitary adenomas.

Authors:  L Persani; P Beck-Peccoz; M Quatrini; M Bassetti; B Travella; P Bianchi; G Faglia
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

7.  Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.

Authors:  V A Fishbeyn; J A Norton; R V Benya; J R Pisegna; D J Venzon; D C Metz; R T Jensen
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.